CHP Merger Stockholders Approve Deadline Extension on Accelus Deal

CHP Merger stockholders voted in favor of extending the SPAC’s merger deadline with Accelus from Nov. 26 until May 26.

Accelus is a medical technology company focused on the spinal surgery market.

The deal values the combined compny at $482 million. If the transaction is approved, funding will come from $300 million held in the SPAC’s trust, as well as $414 million in Acdelus rollover equity, according to a slide deck filed (p. 34) in an 8-K. Read more.

Total
0
Shares
Related Posts